Kestra Private Wealth Services LLC acquired a new stake in Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 15,496 shares of the financial services provider’s stock, valued at approximately $2,688,000.
Several other institutional investors and hedge funds also recently modified their holdings of the stock. State Street Corp purchased a new stake in shares of Marsh & McLennan Companies during the 4th quarter valued at about $4,057,682,000. Capital International Investors acquired a new stake in Marsh & McLennan Companies in the fourth quarter valued at approximately $3,482,557,000. Capital World Investors acquired a new stake in Marsh & McLennan Companies in the fourth quarter valued at approximately $3,140,284,000. Wellington Management Group LLP purchased a new stake in shares of Marsh & McLennan Companies during the fourth quarter valued at approximately $2,967,927,000. Finally, Price T Rowe Associates Inc. MD acquired a new position in shares of Marsh & McLennan Companies during the fourth quarter worth $1,710,101,000. Hedge funds and other institutional investors own 87.99% of the company’s stock.
Marsh & McLennan Companies Stock Performance
Shares of NYSE MRSH opened at $168.83 on Friday. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.11 and a current ratio of 1.11. Marsh & McLennan Companies, Inc. has a 52-week low of $156.60 and a 52-week high of $219.71. The company has a market cap of $81.56 billion, a price-to-earnings ratio of 21.10, a PEG ratio of 2.46 and a beta of 0.62.
Insider Buying and Selling
In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,656 shares of the business’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the completion of the sale, the chief executive officer owned 116,811 shares in the company, valued at $18,889,506.81. The trade was a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
Several research firms recently issued reports on MRSH. Piper Sandler dropped their price target on shares of Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 26th. UBS Group lowered their target price on Marsh & McLennan Companies from $230.00 to $203.00 and set a “buy” rating for the company in a research note on Tuesday, June 9th. Barclays dropped their target price on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 8th. Wells Fargo & Company reduced their price target on Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating for the company in a report on Thursday, April 9th. Finally, Citigroup upgraded Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 price objective for the company in a research note on Wednesday, May 6th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $200.19.
Read Our Latest Report on Marsh & McLennan Companies
Marsh & McLennan Companies Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Featured Stories
- Five stocks we like better than Marsh & McLennan Companies
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
- 3 Waste Stocks Turning AI Investments into Growth
- 3 Overlooked Tech ETFs That Are Quietly Killing It This Year
- 3 ETFs Pairing Market-Beating Returns With High Dividend Yields
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
